Does ROSUVASTATIN Cause Hyperphosphataemia? 25 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Hyperphosphataemia have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.1% of all adverse event reports for ROSUVASTATIN.
25
Reports of Hyperphosphataemia with ROSUVASTATIN
0.1%
of all ROSUVASTATIN reports
20
Deaths
24
Hospitalizations
How Dangerous Is Hyperphosphataemia From ROSUVASTATIN?
Of the 25 reports, 20 (80.0%) resulted in death, 24 (96.0%) required hospitalization, and 12 (48.0%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which ROSUVASTATIN Alternatives Have Lower Hyperphosphataemia Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN